author-photo

Benjamin Margono

The Chinese University of Hong Kong

5

Papers

7133

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC

2017 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (27)
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (327)
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

2013 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (245)
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (23)
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2009 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (6511)